NCT05881967 is a clinical trial of Diagnostic biomarker in Uterine Sarcoma, sponsored by Shixuan Wang.

Who is sponsoring NCT05881967?

NCT05881967 is sponsored by Shixuan Wang.

What drugs are being tested in NCT05881967?

Interventions in NCT05881967: Diagnostic biomarker.

What condition does NCT05881967 study?

NCT05881967 studies Uterine Sarcoma.

Is NCT05881967 still recruiting?

NCT05881967 is currently status unknown. Last updated 31 May 2023.

Last reviewed 2023-05-31 · How we verify

NCT05881967

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Molecular Mechanism Study of Uterine Sarcoma

Status unknown Last updated 31 May 2023

What this trial tests

trial testing Diagnostic biomarker in Uterine Sarcoma in 300 participants. Status unknown.

Timeline

1 March 2023

Primary endpoint
30 November 2025

30 November 2025

Quick facts

Lead sponsor	Shixuan Wang
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	300
Start date	1 March 2023
Primary completion	30 November 2025
Estimated completion	30 November 2025
Sites	1 location across China

Drugs / interventions tested

Diagnostic biomarker

Conditions studied

Uterine Sarcoma — all drugs for Uterine Sarcoma →

Sponsor

Shixuan Wang

Who can join

Adults 18 to 99, female only, with Uterine Sarcoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this project was to use multi-omics technology to screen the key factors for the occurrence and development of uterine sarcoma.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Uterine Sarcoma

Currently open trials in the same condition.

NCT06244251 — Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids · NA · active not recruiting
NCT06805019 — Construction of a Model for the Differential Diagnosis of SArcoma/myoma Based on the RAdiomics Features: Single-center O · recruiting

Other Shixuan Wang trials

Trials by the same sponsor.

NCT05840042 — Epidemiology and Risk Factors of Uterine Fibroids in China · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05881967 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shixuan Wang
Last refreshed: 31 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05881967.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing